Market by Product Type, Industry Verticals, and Country | Forecast 2021-2028
The European sleep apnea therapeutics and diagnostics market is likely to develop with a CAGR of 6.61% over the forecast duration from 2021 to 2028, states a report by Triton Market Research.
The
countries scrutinized in this market include:
•          The United Kingdom
•          Germany
•          Spain
•          France
•          Italy
•          Russia
•          Rest of Europe countries
The
market in France is driven mainly by the presence of regional players like
SEFAM and the favorable reimbursement policies. Before the onset of the
pandemic, France was one of the countries in Europe with a higher rate of
acceptance for sleep apnea teleconsultations. For instance, as per a study by
Pubmed, in May 2018, 78% of the patients preferred telemonitoring. However, 40%
of the patients favored telemonitoring as a means to follow-up instead of
adherence monitoring.
The
market in the United Kingdom is emerging, thanks to the favorable reimbursement
landscape, technological developments in sleep apnea devices, and a high
adoption of PAP devices & adaptive servo-ventilators for therapy. The lack
of medical adherence to therapy, though, majorly restraints the market growth.
However,
the country boasts of an extensive distributor channel for various sleep apnea
devices. For instance, Intus Healthcare is a major distributor of home sleep
testing devices in the country. Users can order the test through the company’s
website. Based on the patients’ physiological data, Intus generates a
comprehensive report, including for sleep apnea diagnosis, if detected.
Signifier
Medical Technologies Limited is a med-tech company that develops and
commercializes innovative and non-invasive solutions for patients affected by
snoring and sleep-disordered breathing conditions. EXciteOSA is the company’s proprietary
therapy, its first and only daytime genioglossal muscle-neurostimulation
technology. With proven clinical data from well-recognized, prestigious universities
and academic institutions, it provides a safe and effective treatment to the
company’s patients. The UK-based company is headquartered in Hammersmith Grove,
London.
1. EUROPE
SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
2.2. KEY
INSIGHTS
2.3. PORTER'S
FIVE FORCES MODEL
2.3.1. BARGAINING
POWER OF BUYERS
2.3.2. BARGAINING
POWER OF SUPPLIERS
2.3.3. THREAT
OF SUBSTITUTE PRODUCTS
2.3.4. THREAT
OF NEW ENTRANTS
2.3.5. COMPETITIVE
RIVALRY
2.4. LEGAL,
POLICY & REGULATORY FRAMEWORK
2.5. SUPPLY
CHAIN OUTLOOK
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. VENDOR
SCORECARD
2.8. KEY
MARKET STRATEGIES
2.8.1. ACQUISITIONS
& MERGERS
2.8.2. NEW
PRODUCT LAUNCHES & DEVELOPMENTS
2.8.3. CONTRACTS
AND PARTNERSHIPS
2.8.4. BUSINESS
EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
2.9. MARKET
DRIVERS
2.9.1. AWARENESS
RELATED TO THE NEGATIVE IMPACT OF UNTREATED SLEEP APNEA
2.9.2. RISE
IN GERIATRIC POPULATION AND OBESITY CASES
2.9.3. DISTURBED
SLEEP DUE TO INCREASED USE OF GADGETS AT NIGHT-TIME
2.10. MARKET
CHALLENGES
2.10.1. HIGH
COST OF SLEEP APNEA DEVICES
2.10.2. UNFAVORABLE
REIMBURSEMENT LANDSCAPE
2.10.3. LACK
OF PATIENT ADHERENCE TO THE TREATMENT RECOMMENDED
2.11. MARKET
OPPORTUNITIES
2.11.1. INCREASING
USAGE OF AT-HOME MONITORING DEVICES
2.11.2. ADVANCEMENTS
IN TECHNOLOGY
3. EUROPE
SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET – BY PRODUCT TYPE
3.1. THERAPEUTICS
3.1.1. POSITIVE
AIRWAY PRESSURE (PAP) DEVICES
3.1.2. OXYGEN
DEVICES
3.1.3. MASKS
AND ACCESSORIES
3.1.4. ORAL
APPLIANCES
3.1.5. ADAPTIVE
SERVO VENTILATION (ASV) DEVICES
3.2. DIAGNOSTICS
AND MONITORING
3.2.1. POLYSOMNOGRAPHY
DEVICE (PSG)
3.2.2. OXIMETER
3.2.3. ACTIGRAPHY
MONITORING DEVICE
3.2.4. RESPIRATORY
POLYGRAPH
3.2.5. SLEEP
APNEA SCREENING DEVICE
3.2.6. OTHER
DIAGNOSTICS AND MONITORING DEVICES
4. EUROPE
SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET – BY INDUSTRY VERTICALS
4.1. HOSPITALS
& SLEEP LABORATORIES
4.2. HOME
CARE SETTINGS
5. GEOGRAPHICAL
ANALYSIS – EUROPE
5.1. COUNTRY
ANALYSIS
5.1.1. GERMANY
5.1.2. FRANCE
5.1.3. UNITED
KINGDOM
5.1.4. ITALY
5.1.5. RUSSIA
5.1.6. SPAIN
5.1.7. REST
OF EUROPE
6. COMPETITIVE
LANDSCAPE
6.1. BMC
MEDICAL CO LTD
6.2. BRAEBON
MEDICAL CORPORATION
6.3. CADWELL
INDUSTRIES INC
6.4. DEVILBISS
HEALTHCARE LLC
6.5. FISHER
& PAYKEL HEALTHCARE CORPORATION LIMITED
6.6. GE
HEALTHCARE (GENERAL ELECTRIC COMPANY)
6.7. INVACARE
CORPORATION
6.8. ITAMAR
MEDICAL LTD
6.9. KONINKLIJKE
PHILIPS NV
6.10. MEDTRONIC
PLC
6.11. NIHON
KOHDEN CORPORATION
6.12. SIGNIFIER
MEDICAL TECHNOLOGIES LIMITED
6.13. RESMED
INC
6.14. SMITHS
MEDICAL INC
6.15. SOMNOMEDICS
GMBH
6.16. TELEFLEX
INCORPORATED
6.17. VYAIRE
MEDICAL INC
7. RESEARCH
METHODOLOGY & SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.1.1. OBJECTIVES
OF STUDY
7.1.2. SCOPE
OF STUDY
7.2. SOURCES
OF DATA
7.2.1. PRIMARY
DATA SOURCES
7.2.2. SECONDARY
DATA SOURCES
7.3. RESEARCH
METHODOLOGY
7.3.1. EVALUATION
OF PROPOSED MARKET
7.3.2. IDENTIFICATION
OF DATA SOURCES
7.3.3. ASSESSMENT
OF MARKET DETERMINANTS
7.3.4. DATA
COLLECTION
7.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: EUROPE SLEEP
APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $
MILLION)
TABLE 2: VENDOR
SCORECARD
TABLE 3: ACQUISITIONS
& MERGERS
TABLE 4: NEW PRODUCT
LAUNCHES & DEVELOPMENTS
TABLE 5: CONTRACTS AND
PARTNERSHIPS
TABLE 6: BUSINESS
EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
TABLE 7: EUROPE SLEEP
APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2028 (IN $
MILLION)
TABLE 8: EUROPE
THERAPEUTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: EUROPE
DIAGNOSTICS AND MONITORING MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 10: EUROPE SLEEP
APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN
$ MILLION)
TABLE 11: EUROPE SLEEP
APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 1: EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET 2021-2028
(IN $ MILLION)
FIGURE 2: PORTER'S FIVE FORCES MODEL
FIGURE 3: EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY
PRODUCT TYPE, 2020 & 2028 (IN %)
FIGURE 4: EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY
THERAPEUTICS, 2021-2028 (IN $ MILLION)
FIGURE 5: EUROPE SLEEP APNEA THERAPEUTICS MARKET, BY POSITIVE AIRWAY
PRESSURE (PAP) DEVICES, 2021-2028 (IN $ MILLION)
FIGURE 6: EUROPE SLEEP APNEA THERAPEUTICS MARKET, BY OXYGEN DEVICES,
2021-2028 (IN $ MILLION)
FIGURE 7: EUROPE SLEEP APNEA THERAPEUTICS MARKET, BY MASKS AND
ACCESSORIES, 2021-2028 (IN $ MILLION)
FIGURE 8: EUROPE SLEEP APNEA THERAPEUTICS MARKET, BY ORAL APPLIANCES,
2021-2028 (IN $ MILLION)
FIGURE 9: EUROPE SLEEP APNEA THERAPEUTICS MARKET, BY ADAPTIVE SERVO
VENTILATION (ASV) DEVICES, 2021-2028 (IN $ MILLION)
FIGURE 10: EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY
DIAGNOSTICS AND MONITORING, 2021-2028 (IN $ MILLION)
FIGURE 11: EUROPE DIAGNOSTICS AND MONITORING MARKET, BY POLYSOMNOGRAPHY
DEVICE (PSG), 2021-2028 (IN $ MILLION)
FIGURE 12: EUROPE DIAGNOSTICS AND MONITORING MARKET, BY OXIMETER,
2021-2028 (IN $ MILLION)
FIGURE 13: EUROPE DIAGNOSTICS AND MONITORING MARKET, BY ACTIGRAPHY
MONITORING DEVICE, 2021-2028 (IN $ MILLION)
FIGURE 14: EUROPE DIAGNOSTICS AND MONITORING MARKET, BY RESPIRATORY
POLYGRAPH, 2021-2028 (IN $ MILLION)
FIGURE 15: EUROPE DIAGNOSTICS AND MONITORING MARKET, BY SLEEP APNEA
SCREENING DEVICE, 2021-2028 (IN $ MILLION)
FIGURE 16: EUROPE DIAGNOSTICS AND MONITORING MARKET, BY OTHER DIAGNOSTICS
AND MONITORING DEVICES, 2021-2028 (IN $ MILLION)
FIGURE 17: EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY
INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 18: EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY
HOSPITALS & SLEEP LABORATORIES, 2021-2028 (IN $ MILLION)
FIGURE 19: EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY
HOME CARE SETTINGS, 2021-2028 (IN $ MILLION)
FIGURE 20: GERMANY SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET 2021-2028
(IN $ MILLION)
FIGURE 21: FRANCE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET 2021-2028
(IN $ MILLION)
FIGURE 22: UNITED KINGDOM SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
2021-2028 (IN $ MILLION)
FIGURE 23: ITALY SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET 2021-2028
(IN $ MILLION)
FIGURE 24: RUSSIA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET 2021-2028
(IN $ MILLION)
FIGURE 25: SPAIN SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET 2021-2028
(IN $ MILLION)
FIGURE 26: REST OF EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
2021-2028 (IN $ MILLION)